Switching to long-acting CAB/RPV was not linked to HBV reactivation or incident infection and may be a safe therapeutic option for most patients with HIV.
Latest stories by Nidhi Loomba. Nidhi Loomba writes for ETHealthworld.com and gives views & updates on the Indian Health ...
The Ministry of Health and Social Services has registered lenacapavir, a long-acting HIV prevention medication administered twice a year, as part of efforts to strengthen the country's HIV prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results